Drug Shortage Report for ROFACT

Last updated on 2023-02-24 History
Report ID 176953
Drug Identification Number 00343617
Brand name ROFACT
Common or Proper name ROFACT
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) RIFAMPIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100's
ATC code J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2022-11-24
Estimated end date 2023-03-30
Actual end date 2023-02-23
Shortage status Resolved
Updated date 2023-02-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2023-02-24 English Compare
v12 2023-02-23 French Compare
v11 2023-02-23 English Compare
v10 2023-01-19 French Compare
v9 2023-01-19 English Compare
v8 2023-01-18 French Compare
v7 2023-01-18 English Compare
v6 2023-01-11 French Compare
v5 2023-01-11 English Compare
v4 2022-12-21 French Compare
v3 2022-12-21 English Compare
v2 2022-12-02 French Compare
v1 2022-12-02 English Compare

Showing 1 to 13 of 13